Skip to Main Content

Author Details

Angela B Y Hui
Stanford University
1996
70
40
PMIDPaper TitleJournal TitlePublished Year
36129469CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer.Clin Cancer Res2022
32269342Integrating genomic features for non-invasive early lung cancer detection.Nature2020
34505064Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.Nat Cancer2020
32046999Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.Clin Cancer Res2020
31711920Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.Gastroenterology2020
33007267Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.Cell2020
32381040A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.Genome Biol2020
31836708Functional significance of U2AF1 S34F mutations in lung adenocarcinomas.Nat Commun2019
28008921Reprogramming the immunological microenvironment through radiation and targeting Axl.Nat Commun2016
25738365Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma.Oncotarget2015
25880806Developing a prognostic micro-RNA signature for human cervical carcinoma.PLoS One2015
25970788Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.Oncotarget2015
25944123Chromosomal instability as a prognostic marker in cervical cancer.BMC Cancer2015
25271301Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.Mol Cell Proteomics2014
22917550Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.Oral Oncol2013
24184275The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.Cancer Epidemiol2013
23861821MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.PLoS One2013
23878065Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.J Pathol2013
23991213Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.PLoS One2013
23459718Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma.Clin Cancer Res2013
23505015Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery.Proteomics2013
23335975MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.PLoS One2013
23295795Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.J Clin Oncol2013
22410204Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.Radiother Oncol2012
22918226Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.Mol Cell Proteomics2012
22926973A spectrum of basaloid morphology in a subset of EBV-associated "lymphoepithelial carcinomas" of major salivary glands.Head Neck Pathol2012
21270338Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.Sci Transl Med2011
22031094Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.Clin Cancer Res2011
22128797Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies.BMC Cancer2011
21385904MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.Cancer Res2011
21393507MicroRNA-301 mediates proliferation and invasion in human breast cancer.Cancer Res2011
19739117Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.Int J Cancer2010
21368858Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98.Cell Death Dis2010
20145181Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.Clin Cancer Res2010
19718711Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.J Pathol2010
19287953Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.Int J Oncol2009
19884544Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.J Clin Oncol2009
19810065Direct, electronic microRNA detection for the rapid determination of differential expression profiles.Angew Chem Int Ed Engl2009
19575017Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.Cell Death Differ2009
19470731Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.Clin Cancer Res2009
19290006Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.Lab Invest2009
18676763Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.Clin Cancer Res2008
17141974East-West Symposium on nasopharyngeal cancer.Int J Radiat Oncol Biol Phys2007
170773314q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4.Blood2007
16114017PIK3CA mutations in nasopharyngeal carcinoma.Int J Cancer2006
15586224Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines.Int J Oncol2005
16166286Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma.Cancer Res2005
16306110Investigation of the genomic representation of plasma DNA in pregnant women by comparative genomic hybridization analysis: a feasibility study.Clin Chem2005
16000565Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.Clin Cancer Res2005
14758948Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.J Neurosurg2004
  • 1 - 50 of 70

Recommended Authors

Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Career Start Year 2013
Number of shared co-authors 0
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Ken Miyaguchi
Maxine-Dunitz Neurosurgical Institute, Cedars Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 0
Pinaki Bose
Cumming School of Medicine, University of Calgary
Career Start Year 2008
Number of shared co-authors 1
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Darawalee Wangsa
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Bin Feng
The First Affiliated Hospital of Jinan University
Career Start Year 2004
Number of shared co-authors 0
Rifat Hasina
University of Chicago Medicine
Career Start Year 1999
Number of shared co-authors 0
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 8
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 0
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 1
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Alexei Protopopov
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Mitchell J Frederick
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 1
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 6
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 3
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 6
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 1
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 30
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 11
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 1
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 6
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 4
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 6
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 5
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 6

Collaborators

Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 33
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 22
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Co-authored papers 20
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 14
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 13
Ho-Keung Ng
Chinese University of Hong Kong
Co-authored papers 12
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 11
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Co-authored papers 11
Bayardo Perez-Ordonez
University Health Network
Co-authored papers 10
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 10
Ilan Weinreb
University Health Network
Co-authored papers 8
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Jonathan C Irish
Princess Margaret Cancer Centre
Co-authored papers 6
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 5
Aadel A Chaudhuri
Co-authored papers 5
Paul C Boutros
University of California los angeles
Co-authored papers 5
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Christine How
Ontario Cancer Institute, University Health Network (UHN)
Co-authored papers 4
Wai Sang Poon
Prince of Wales Hospital
Co-authored papers 4
Levi Waldron
City University of New York School of Public Health
Co-authored papers 4
Steven H Lin
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Ralph W Gilbert
Princess Margaret Cancer Centre
Co-authored papers 3
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Richard P Hill
Princess Margaret Cancer Centre
Co-authored papers 3
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Blaise A Clarke
University of Toronto.
Co-authored papers 3
Carlo Bastianutto
University of Toronto
Co-authored papers 3
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 3
Daryl Waggott
Ontario Institute for Cancer Research
Co-authored papers 3
Aaron M Newman
Stanford University
Co-authored papers 3
Release 1.2